Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Hyperglycemia increases the risk of cardiovascular disease: epidemiological evidence

July 22, 1997

D1/D2 combination therapy results reported at the 16th IDF congress

July 22, 1997

RPR seeks approval for Menorest in Japan

July 22, 1997

U.S. patent allowance for Cypress Bioscience's IPM product

July 22, 1997

Steroids from Jenapharm for contraception/HRT

July 22, 1997

New treatment in development for Pompe's disease

July 21, 1997

Once-daily atorvastatin vs. pravastatin for hypercholesterolemia

July 16, 1997

Senetek files third PLA for INVICORP

July 16, 1997

Mianserin studied for treatment of sexual dysfunction

July 16, 1997

New oral antidiabetic agents disclosed

July 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...